Lighting up Tumors with Phospholipid Compounds (6 of 6) (image) American Association for the Advancement of Science Share Print E-Mail Caption Preferential cancer cell uptake of CLR1501 is shown. Fluorescence confocal microscopy illustrates that the fluorescent CLR1404 analogue, CLR1501, is selectively retained in three additional cancer types at 24 hours post treatment. This image relates to a paper that appeared in the June 11, 2014, issue of Science Translational Medicine, published by AAAS. The paper, by Dr. J.P. Weichert at the University of Wisconsin School of Medicine and Public Health in Madison, Wis., and colleagues was titled, "Alkylphosphocholine Analogs for Broad-Spectrum Cancer Imaging and Therapy." Credit Weichert et al., Science Translational Medicine 2014 Usage Restrictions Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact Science for permission. Share Print E-Mail Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.